Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Progress in oncogene and antioncogene research].

K Toyoshima¹, T Akiyama

¹Dept. of Oncogene Research, Institute for Microbial Diseases, Osaka University, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy

|June 1, 1992

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Health-Related Quality of Life in Japanese Youth Born Extremely Low-Birthweight: Impact of Attention Deficit Hyperactivity Disorder.

Acta paediatrica (Oslo, Norway : 1992)·2025

Same author

Indocyanine green lymphography in the congenital chylothorax and chylous ascites.

Journal of neonatal-perinatal medicine·2024

Same author

Reopening of ductus arteriosus in idiopathic premature constriction or closure of ductus arteriosus: A case series.

Journal of neonatal-perinatal medicine·2023

Same author

Difference between "Physical Fitness Age" Based on Physical Function and Chronological Age Is Associated with Obesity, Hyperglycemia, Depressive Symptoms, and Low Serum Albumin.

The journal of nutrition, health & aging·2022

Same author

Correction: Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication.

Oncogenesis·2019

Same author

Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication.

Oncogenesis·2017

Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

See all related articles

Cancer cell growth is driven by oncogenes, which result from proto-oncogene mutations. Tumor progression also requires the inactivation of antioncogenes, highlighting the genomic changes critical for malignancy.

Area of Science:

Molecular biology
Cancer research
Genetics

Context:

Cancer development involves complex genetic alterations.
Proto-oncogenes regulate cell growth.
Antioncogenes act as tumor suppressors.

Purpose:

To explain the dual genetic mechanisms driving tumor cell proliferation.
To elucidate the role of oncogenes and antioncogenes in cancer progression.

Summary:

Mutations activating proto-oncogenes yield oncogenes, promoting tumor cell growth.
Inactivation of antioncogenes also contributes to tumor cell generation.
Malignant tumor progression often necessitates both oncogene activation and antioncogene inactivation.

Impact:

Related Experiment Videos

Provides a foundational understanding of cancer's molecular basis.
Identifies key genetic targets for cancer therapy.
Highlights the importance of genomic stability in preventing cancer.